Mr. Rabin Mukhopadhyay
Dr. Bruce serves as Vice President of Medical Affairs For Oramed Pharmaceuticals. Dr Bruce has made important contributions to new product development and clinical therapeutics in diabetes and metabolism over the past 20 years. He has broad experience across all phases of clinical development and has been responsible for clinical development strategy and execution from pre-IND to first-in-human through Phase 3 planning, execution and filing. He has led clinical development of multiple compounds in the metabolic and diabetes therapeutic areas including DPP4 and SGLT2 inhibitors, GLP-1 agonists, leptin and prandial insulins among others. He has trained in Internal Medicine with sub-specialization in Endocrinology at the NIH. He has held positions of increasing responsibility in both large pharmaceutical and small to medium sized biotech companies. Most recently he served as Chief Medical Officer with Adocia Inc., working on an ultra-rapid insulin in collaboration with Eli Lilly.